Sure Med Compliance Partners with Synergy Laboratories to Advance the Fight Against Opioid Abuse
MOBILE, Ala.--(BUSINESS WIRE)--Jan 8, 2019--Sure Med Compliance ® (SMC) and Synergy Laboratories (Synergy) are providing physicians a new weapon in the critical fight to combat the opioid epidemic. As a result of the two companies’ partnership, diagnostic results such as urine drug screens can now be reported to the same dashboard that warns a provider of patient red flags found through the Sure Med Compliance patient evaluations.
“The opioid epidemic is affecting thousands of families in Alabama, and has ruined too many lives. As a laboratory with a conscience, we believe we have a moral obligation to do everything in our power to provide physicians with every advantage when deciding if opioids are the preferred treatment option,” said Brad Pitts, Synergy’s Chief Executive Officer. He added, “Laboratory results often provide the first sign of substance misuse and deploying this technology will allow physicians to make more informed prescribing decisions.”
John Bowman, Sure Med Compliance’s Chief Executive Officer, echoed Pitts’ comments, and highlighted the common vision that both companies have for this partnership. He said, “We knew partnering with a diagnostic laboratory was necessary for building a solution that could start turning the tide of the opioid epidemic. In Synergy, we have found a partner whose technology will enhance our reporting and screening tools and the fact that they share so many of our core beliefs is icing on the cake.”
The two Mobile, Alabama based companies are planning more strategic partnerships across different industries and have begun developing new software to help manage patients on other controlled substances as well as patients being treated for addiction.
Sure Med Compliance has a vision of ending the opioid epidemic through greater prescribing compliance. This is achieved through training, chart auditing, software integration and providing physicians with a written diversion control plan. In a short period of time, Sure Med Compliance has made a big impact on prescribing habits in the Southeast United States and become the market leader in opioid prescribing compliance.
Synergy Laboratories is a full-service, diagnostic laboratory that performs clinical, toxicology and genetic testing. Founded in 2015, by Brad Pitts and Brandon Biles, Synergy’s mission is to ethically serve the healthcare sector and give healthcare providers quality service and accurate results. In recent years, Synergy has sharpened their focus to helping end the opioid epidemic and has become an outspoken voice against over-testing and exploitation of the healthcare system.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190108005340/en/
CONTACT: Barkley Busby
Chief Marketing Officer • (866) 517-2771
(251) 662-9760 •Morgan.Myers@synergytesting.com
KEYWORD: UNITED STATES NORTH AMERICA ALABAMA
INDUSTRY KEYWORD: TECHNOLOGY DATA MANAGEMENT SOFTWARE HEALTH HOSPITALS PHARMACEUTICAL GENERAL HEALTH
SOURCE: Sure Med Compliance
Copyright Business Wire 2019.
PUB: 01/08/2019 10:05 AM/DISC: 01/08/2019 10:05 AM